Mesoblast Limited (ASX:MSB)
Australia · Delayed Price · Currency is AUD 1.992
+0.007 (0.35%)
Apr 8, 2026, 12:59 PM AEST
Mesoblast Market Cap
Mesoblast has a market cap or net worth of 2.56 billion as of April 7, 2026. Its market cap has decreased by -9.93% in one year.
Market Cap
2.56B
Enterprise Value
2.57B
Revenue
98.02M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.99
Market Cap Chart
Since December 16, 2004, Mesoblast's market cap has increased from 76.57M to 2.56B, an increase of 3,246.28%. That is a compound annual growth rate of 17.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 2.75B | -21.21% |
| Dec 31, 2025 | 3.49B | -1.80% |
| Dec 31, 2024 | 3.55B | 1,029.56% |
| Dec 29, 2023 | 314.59M | -50.91% |
| Dec 30, 2022 | 640.82M | -29.87% |
| Dec 31, 2021 | 913.81M | -30.79% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Telix Pharmaceuticals | 4.39B |
| Neuren Pharmaceuticals | 1.52B |
| Clarity Pharmaceuticals | 1.17B |
| PYC Therapeutics | 1.10B |
| Opthea | 738.77M |
| Racura Oncology | 479.29M |
| Clinuvel Pharmaceuticals | 452.81M |
| Tetratherix | 220.32M |